Liver T1 ρ value increased mildly on 48 hours and further increased as the degeneration and necrosis of hepatocytes, while fibrosis appeared and progressed at weeks 2, 4, and 6.
The pattern continued to progress at week 8 with a significant 60.5% increase in marrow lipids and a 13.3% decrease in BMD when compared to baseline readings.
Although all three patients with melanoma randomised to sorafenib progressed at 12 weeks postrandomisation (24 weeks from initiation); only two were discontinued.
The groove model showed only very mild changes in cartilage integrity at 3 weeks, which progressed at 10 and 20 weeks.
Patients who progressed at the 27-week planned scan, regardless of the actual calendar date of that scan, were declared as having progressed at 6 months.
All patients had previously undergone chemotherapy with the weekly Irinotecan (60 mg/m)+5-FU (400 mg/m)+LV (200 mg/m) regimen (with no planned breaks unless the occurrence of grade III toxicity or PD) and had achieved a CR/PR or SD and progressed at least 8 weeks off treatment.
The decline in heart rate of the diabetic animals progressed at measures 6 and 10 weeks after streptozotocin induced diabetes (figure 1).
Growth for the iPhone 5 progressed at about 0.25 to 0.5percentt per week, according to Mixpanel, and the growth for the iPhone 5s is currently trending at around 0.75 and 1percentt per week.
Throughout the 12 weeks, the patient gradually progressed at her own pace to 80% of her 10RM.
"They haven't progressed at all yet.
